Publication|Articles|December 15, 2023
Supplements and Featured Publications
- Managed Care Considerations in the Treatment of Hemophilia B and Hemophilia A: A Review of Results from Real-World Analyses Comparing Expenditures and Factor Dispensation
Managed Care Considerations in the Treatment of Hemophilia B and Hemophilia A: A Review of Results from Real-World Analyses Comparing Expenditures and Factor Dispensation
Advertisement
This AJMC® brochure focuses on managed care considerations in the treatment of Hemophilia B and Hemophilia A.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
5
